Here are relevant reports on : fund-administration-market
-
Europe Vaccines Market by Technology (Conjugate, Recombinant, Inactivated, Live Attenuated, Viral Vector, mRNA), Type (Monovalent, Multivalent), Disease (Pneumococcal, Flu, Hepatitis, MMR, RSV), Route of Administration (IM, SC, Oral) - Forecast to 2030
The Europe vaccines market, valued at US$10.53 billion in 2024, stood at US$9.97 billion in 2025 and is projected to advance at a resilient CAGR of 6.6% from 2025 to 2030, culminating in a forecasted valuation of US$13.74 billion by the end of the period. The vaccines market is growing due to fast global developments and the commercialization of vaccines, rising rates of infectious diseases, which require preventive measures, and government initiatives to encourage vaccinations, immunization programs, advancements, and investments in new vaccines against various diseases.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
US Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Infectious Diseases, Cancer, Obesity), Usage Pattern (Immunization), Administration (Skin, Musculoskeletal), End Users (Hospital, Home Care) - Forecast to 2031
The US injectable drug delivery market, valued at US$285.81 billion in 2025, stood at US$309.90 billion in 2026 and is projected to advance at a resilient CAGR of 8.5% from 2026 to 2031, culminating in a forecasted valuation of US$465.15 billion by the end of the period. The growth of the veterinary contract manufacturing & research market is driven by the increasing adoption of biologics and long-acting injectables, rising demand for patient-centric and self-administration delivery systems, and the need for advanced formulation, device engineering, and scalable manufacturing capabilities.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Veterinary Dermatology Market by Route of Administration, Product type (Antibacterial, Antifungal, Antiparasitic Drugs, Monoclonal Antibodies), Condition type (Parasitic Infections, Infectious Diseases, Skin Cancer), Animal type - Global Forecast to 2030
Global veterinary dermatology market valued at $18.59B in 2024, reached $20.11B in 2025, and is projected to grow at a robust 8.5% CAGR, hitting $ 30.31B by 2030. The major factors that are driving the market are expanding companion animal population and pet ownership, growing concerns about infectious zoonotic diseases, rising awareness initiatives by government and animal welfare organizations, and increased adoption of pet insurance and high animal healthcare expenditure.
- Published: February 2025
- Price: $ 4950
- TOC Available:
-
Europe Contrast Media Market by Product (Microbubble, Iodine, Gadolinium, Barium-based), Modality (CT, MRI, Ultrasound), Indication (Cancer, GIT, CVD, Musculoskeletal, Neurology, Urology), Route of Administration (IV, Oral), End User - Forecast to 2031
The Europe contrast media market is projected to reach USD 3.19 billion by 2031, growing at a CAGR of 7.5% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Dental Anesthetics Market by Drug Type (Lidocaine, Mepivacaine, Articaine, Bupivacaine, Mepivacaine, Prilocaine), Route of Administration (Topical, Injectable, Syringes, Needles), End User (Hospitals, Clinics, Others), Region - Global Forecast to 2030
The global dental anesthetics market, valued at US$1.43 billion in 2024, stood at US$1.48 billion in 2025 and is projected to advance at a resilient CAGR of 4.0% from 2025 to 2030, culminating in a forecasted valuation of US$1.80 billion by the end of the period. Several factors are driving the global market for dental anesthetics
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Osteoarthritis Therapeutics Market by Anatomy (Knee, Hand), Drug Type (NSAIDs, Analgesics, Corticosteroids), Route of Administration (Parenteral), Distribution Channel (Hospital Pharmacies), Purchasing Pattern (Prescription Drugs) - Global Forecasts to 2025
The global osteoarthritis therapeutics market growth is primed to transition from USD 7.3 billion in 2020 to USD 11.0 million by 2025, showcasing a strong CAGR of 8.7%.
- Published: December 2020
- Price: $ 4950
- TOC Available:
-
Latin America Pharmaceutical Drug Delivery Market by Route of Administration [Injectable (Prefilled Syringe, Self Injection Devices), Oral (Tablet, Capsule, Liquid), Topical, Buccal, Nasal, Rectal], Application (Cancer, Diabetes, CVD) - Forecast to 2031
The latin america pharmaceutical drug delivery market, valued at USD 72.7BN in 2025, stood at USD 75.3BN in 2026 and is projected to advance at a resilient CAGR of 6.3% from 2026 to 2031, culminating in a forecasted valuation of USD 102.1BN by the end of the period. Some of the prominent players in the Latin America pharmaceutical drug delivery market include Pfizer Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Novartis AG (Switzerland), Sanofi (France), AstraZeneca (UK), GSK Plc (UK), Eurofarma (Brazil), Bayer AG (Germany), EMS (Brazil), BD (US), Teva Pharmaceutical Industries Ltd. (Israel), and Hypera Pharma (Brazil).
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Vascular Access Device Market by Type [Central, Peripheral Venous (PIVC, Midline, Arterial), Intraosseous], Route of Insertion, Application [Drug, Fluid Administration, Diagnostic & Testing], End User [Hospital (Public, Private)] - Forecast to 2031
The vascular access device market, valued at USD 5.92 billion in 2025, stood at USD 6.27 billion in 2026 and is projected to advance at a resilient CAGR of 6.7% from 2026 to 2031, culminating in a forecasted valuation of USD 8.68 billion by the end of the period. The market's expansion is attributed to the increasing prevalence of chronic diseases requiring frequent or long-term treatment through IV, such as cancer, heart disease, and kidney failure.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Elastomeric Pumps Market by Product (Continuous Rate, Variable Rate), Treatment (Chemotherapy, Antibiotic, Iron Chelation Therapy), Administration Route (Intravenous, Subcutaneous), End User (Hospital, Ambulatory Surgery Center) - Global Forecast to 2022
The global elastomeric pumps market is expected to reach USD 592.0 Million by 2022 from USD 432.1 Million in 2017, growing at a CAGR of 6.5% from 2017 to 2022. Increasing number of surgeries, wide usage in treatment, rising incidence of chronic diseases, and increasing adoption for disposable infusion pumps, are some of the major driving factors driving the growth of the global elastomeric pumps market. However, the high cost of treatment and challenges in reimbursement are hindering the growth of this market to a certain extent.
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Asia Pacific Enteral Feeding Devices Market, by Type (Administration sets, Nasogastric Tubes, Enteral Feeding Syringes, Nasal Feeding, Nasoduodenal), Insertion Method, Age Group (Adult, Pediatric), Application (Oncology, Respiratory), End User - Forecast to 2032
The Asia Pacific enteral feeding device market, valued at USD 0.76 billion in 2025, stood at USD 0.80 billion in 2026 and is projected to advance at a resilient CAGR of 6.8% from 2026 to 2032, culminating in a forecasted valuation of USD 1.20 billion by the end of the period. In the Asia Pacific enteral feeding devices market, the growth of enteral feeding tubes is primarily attributed to the incidence of diseases such as cancer, stroke, neurological disorders, and gastrointestinal diseases that often lead to swallowing difficulties and require prolonged nutrition support.
- Published: June 2026
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
